Blood Pressure Reduction Is Not the Only Determinant of Outcome
Authors:
- Peter S SeverPSPeter S Sever
- William J ElliottWEWilliam J Elliott
- M Charlotte JonssonMJM Charlotte Jonsson
- Henry R BlackHBHenry R Black
- 13 June 2006
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 113 (23) , 2754-2774
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke PreventionHypertension, 2005
- Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary PreventionStroke, 2005
- Benefits from angiotensin-converting enzyme inhibitor ‘beyond blood pressure lowering’: beyond blood pressure or beyond the brachial artery?Journal Of Hypertension, 2005
- The Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)2005
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapyExpert Opinion on Pharmacotherapy, 2004
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid AtherosclerosisCirculation, 2002
- Clinical results of the Verapamil in Hypertension and Atherosclerosis StudyJournal Of Hypertension, 1997
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990